Local Kappa Opioid Receptor Activation Decreases Temporomandibular Joint Inflammation
- 12 April 2011
- journal article
- Published by Springer Nature in Inflammation
- Vol. 35 (1) , 371-376
Abstract
In an attempt to decrease central side effects associated with the use of opioids, some strategies have been developed by targeting peripheral opioid receptors. In this context, kappa receptors are of major interest, since, in contrast to other opioid receptors, their activation is not associated with potent peripheral side effects. We have recently demonstrated that local activation of kappa opioid receptors significantly decreases formalin-induced temporomandibular joint nociception; however, whether it also decreases temporomandibular joint inflammation is not known. To address this issue, we evaluated if a specific kappa opioid receptor agonist, U50,488 (trans-(1S,2S)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl] benzeneacetamide hydrochloride hydrate), administered into the temporomandibular joint decreases formalin-induced plasma extravasation and neutrophil migration. Ipsilateral, but not contralateral, administration of U50,488 into the temporomandibular joint blocked formalin-induced plasma extravasation and neutrophil migration in a dose-dependent manner. This anti-inflammatory effect was reversed by the ipsilateral, but not contralateral, administration of the kappa opioid receptor antagonist nor-BNI (nor-binaltorphimine dihydrochloride). This study demonstrates that local activation of kappa opioid receptors decreases two important parameters of temporomandibular joint inflammation, that is, plasma extravasation and neutrophil migration, in a dose-dependent and antagonist-reversible manner. This anti-inflammatory effect taken together with the potent antinociceptive effect, suggests that drugs targeting peripheral kappa opioid receptors are promising for the treatment of inflammatory temporomandibular joint pain and probably, other articular pain conditions with an inflammatory basis.Keywords
This publication has 22 references indexed in Scilit:
- Peripheral kappa opioid receptors activation reduces alveolar bone loss in rats by modulating interleukin-6 and -10Archives of Oral Biology, 2011
- Analgesic Effects of Intra-Articular Morphine in Patients With Temporomandibular Joint Disorders: A Prospective, Double-Blind, Placebo-Controlled Clinical TrialJournal of Oral and Maxillofacial Surgery, 2010
- Opioid Receptors2009
- Inflammatory pain is enhanced in delta opioid receptor‐knockout miceEuropean Journal of Neuroscience, 2008
- Intra-Articular Morphine for Inflammatory PainRegional Anesthesia & Pain Medicine, 2006
- Intra-Articular Morphine for Inflammatory PainRegional Anesthesia & Pain Medicine, 2006
- Antiexudative Effects of Opioids and Expression of κ- and δ- Opioid Receptors during Intestinal Inflammation in Mice: Involvement of Nitric OxideThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Sexual dimorphism in the antinociception mediated by kappa opioid receptors in the rat temporomandibular jointNeuroscience Letters, 2004
- Effect of the peripherally selective κ‐opioid agonist, asimadoline, on adjuvant arthritisBritish Journal of Pharmacology, 1998
- Ethical guidelines for investigations of experimental pain in conscious animalsPain, 1983